News

The company hopes to stand out with Diabegone, a diabetes treatment that lasts longer than competing drugs from companies ...
ET Net News Agency, 12 August 2025] CSPC PHARMA (01093) fell 2.8% to HK$10.07. It hits an intra-day low of HK$10.02, and an intra-day high of HK$10.46. The total shares traded was 83.88 million, with ...
Madrigal Pharmaceuticals, Inc.'s Rezdiffra saw Q2 net sales soar 55% to $212.8M amid strong growth. EU approval expected by ...
Madrigal Pharma secures global rights to SYH2086, a GLP-1 receptor agonist. Read more here.
Madrigal Pharmaceuticals has agreed to enter into a global license agreement with CSPC Pharmaceutical Group Limited for its preclinical oral small molecule glucagon-like-peptide-1 (GLP-1) receptor ...
Madrigal Pharmaceuticals Inc. and CSPC Pharmaceutical Group Ltd. have entered into an exclusive global license agreement for CSPC’s SYH-2086, a preclinical oral small-molecule glucagon-like peptide-1 ...
Madrigal Pharmaceuticals Inc. and CSPC Pharmaceutical Group Ltd. have entered into an exclusive global license agreement for CSPC’s SYH-2086, a preclinical oral small-molecule glucagon-like peptide-1 ...
U.S. drugmaker Madrigal Pharmaceuticals has struck a licensing deal with CSPC Pharmaceutical Group that could be worth more than $2 billion for the Chinese company if it results in a new drug for ...
CSPC Pharmaceutical Group ( ($HK:1093) ) has issued an announcement. CSPC Innovation Pharmaceutical Co., Ltd., a subsidiary of CSPC Pharmaceutical ...
Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited Provided by GlobeNewswire Jul 30, 2025, 2:00:00 AM ...
Financial Considerations Under the agreement, CSPC has granted Madrigal an exclusive global license to develop, manufacture, and commercialize SYH2086.
Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited Read Next Aurora Mobile’s GPTBots.ai to Integrate Zhipu ...